May 12, 2015—The Health Resources and Services Administration has updated the current quarter's 340B Medicaid Exclusion File to correct the inadvertent omission of 418 covered entity sites when HRSA originally published the list in mid-March. … [Read more...]
Global Spending on Cancer Drugs Reached $100 Billion in 2014
Spending expected to keep rising up to 8 percent per year through 2018May 11, 2015—Global spending on cancer treatment and support medicines reached $100 billion in 2014, up from $75 billion five years earlier, the IMS Institute for Healthcare Informatics reports. … [Read more...]
340B Recertification for Title X Centers Starts This Week
Drugmakers have been asked to update their 340B database files by May 15May 11, 2015—Annual recertification of 340B eligibility Title X family planning clinics begins on May 13 and will end on June 10, according to a notice on the Health Resources and Services Administration Office of Pharmacy Affairs home page. … [Read more...]
HRSA Sends 340B Omnibus Guidance to OMB
Timing points to publication for notice and comment this summerMay 6, 2015—The Health Resources and Services Administration today sent its proposed 340B program omnibus guidelines to the White House Office of Management and Budget for review prior to publication in the Federal Register. … [Read more...]
Hospital Group Changes Name to 340B Health
New name reflects focus on healthy communities, says the former SNHPAMay 6, 2015—Safety Net Hospitals for Pharmaceutical Access, which represents more than 1,000 hospitals enrolled in the 340B drug discount program, has changed its name to 340B Health. … [Read more...]
Study: CMS Overpays for Home Infusion Drugs
New payment methodology would save hundreds of millions of dollars, OIG saysApril 30, 2015—Medicare could have saved more than a quarter of a billion dollars during a recent 18-month period if it had changed how it pays for drug infusions that patients often receive at home, the Department of Health and Human Services Office of Inspector General says in a new report. … [Read more...]
OIG Nudges Congress and CMS on Medicare Part D Drug Rebates
Medicaid drug rebates are substantially higher, it notesApril 29, 2015—Congress and the Centers for Medicare & Medicaid Services should take a harder look at obtaining additional prescription drug rebates under Medicare Part D, the Health and Human Services Office of Inspector General recommends in a new report. … [Read more...]